AI in Medicine News ・ 💊 Drug discovery and clinical trials

AI Is Making Drug Pipelines Bigger. It Might Also Be Making Them Worse.

The Clinical Trial Vanguard · 11/03 13:07 UTC

Daphne Koller agrees with Bruce Booth that AI molecular design will worsen pharma R&D productivity before improving it. The piece discusses what the industry must fix first.

Read the original (The Clinical Trial Vanguard)

See it in the digest → ・ See this issue →